MedTrace Logo

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

NCT00180297 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 215

Last updated 2021-10-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the safety and efficacy of the implant of a ICD lead of defibrillation in the septum of the right ventricle

Conditions

  • Ventricular Tachycardia
  • Ventricular Fibrillation

Interventions

DEVICE

Endotak Reliance G

Reliance G is a defibrillation lead to be placed in the right ventricle.

Sponsors & Collaborators

  • Guidant Corporation

    collaborator INDUSTRY

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Philippe Mabo, MD · Hôpital Pontchaillou, Rennes, France

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00180297 on ClinicalTrials.gov